Embecta (FRA:JX7) YoY EBITDA Growth : 53.81% (As of Mar. 2025)

View and export this data going back to 2022. Start your Free Trial

What is Embecta YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Embecta's YoY EBITDA Growth for the quarter that ended in Mar. 2025 was 53.81%.

Embecta's EBITDA per Share for the three months ended in Mar. 2025 was €1.17.

Embecta YoY EBITDA Growth Historical Data

The historical data trend for Embecta's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Embecta YoY EBITDA Growth Chart

Embecta Annual Data

Trend

Sep19

Sep20

Sep21

Sep22

Sep23

Sep24

YoY EBITDA Growth

Get a 7-Day Free Trial

-8.91

1.86

-26.05

-32.33

-25.18

Embecta Quarterly Data
	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
YoY EBITDA Growth	Get a 7-Day Free Trial														-20.87	19.55	-37.46	-21.84	53.81

Embecta YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Embecta's YoY EBITDA Growth for the fiscal year that ended in Sep. 2024 is calculated as:

	YoY EBITDA Growth (A: Sep. 2024 )
=	(EBITDA per Share (A: Sep. 2024 )	-	EBITDA per Share (A: Sep. 2023 ))	/	\| EBITDA per Share (A: Sep. 2023 ) \|
=	(2.977	-	3.979)	/	\| 3.979 \|
=	-25.18 %

Embecta's YoY EBITDA Growth for the quarter that ended in Mar. 2025 is calculated as:

	YoY EBITDA Growth (Q: Mar. 2025 )
=	(EBITDA per Share (Q: Mar. 2025 )	-	EBITDA per Share (Q: Mar. 2024 ))	/	\| EBITDA per Share (Q: Mar. 2024 )) \|
=	(1.172	-	0.762)	/	\| 0.762 \|
=	53.81 %

Embecta YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Embecta's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Embecta Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Embecta Corp (FRA:JX7) » Definitions » YoY EBITDA Growth

Comparable Companies

Traded in Other Exchanges

EMBC:USA JX7:Germany

Address

300 Kimball Drive, Suite 300, Parsippany, NJ, USA, 07054

Website

https://www.embecta.com

Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.

Embecta Headlines

No Headlines